Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 13, 2025
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Journal: JAMA network open
Published: December 28, 2023
In Reply to Hannoun-Levi et al.
Journal: International journal of radiation oncology, biology, physics
Published: February 12, 2022
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors.
Journal: Cardio-oncology (London, England)
Published: October 18, 2021
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 16, 2021
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Journal: NPJ breast cancer
Published: September 12, 2021
Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: July 28, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 14, 2021
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Journal: Nature communications
Published: March 25, 2021
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Journal: The oncologist
Published: December 01, 2020
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Journal: NPJ breast cancer
Published: November 23, 2020
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
Journal: Clinical breast cancer
Published: November 12, 2020
Last Updated: 09/26/2026